Amneal Pharmaceuticals, Inc. 10-Q filing
Filed 2025-08-07 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001723128-25-000047
- Form type
- 10-Q
- CIK
- 0001723128
- Primary document
- https://www.sec.gov/Archives/edgar/data/1723128/000172312825000047/amrx-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Amneal Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $1.4B | - | - |
| Cost Of Revenue | $877.8M | - | - |
| Gross Profit | $542.1M | - | - |
| Operating Income | $211.7M | - | - |
| Net Income | $34.6M | - | - |
| Eps Basic | 0.11 | - | - |
| Eps Diluted | 0.11 | - | - |
| Cash And Equivalents | $71.5M | - | - |
| Total Assets | $3.4B | - | - |
| Shareholders Equity | $-112.1M | - | - |
| Operating Cash Flow | $91.2M | - | - |
| Capital Expenditures | $36.0M | - | - |